<DOC>
	<DOCNO>NCT02640651</DOCNO>
	<brief_summary>The purpose pilot study determine whether transcranial direct current stimulation safely effectively improve symptom ADHD .</brief_summary>
	<brief_title>An Study Transcranial Direct Current Stimulation Adults With ADHD</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<criteria>Male female adult 1865 year age . A diagnosis childhood onset ADHD , meet Diagnostic Statistical Manual Mental Disorders , Fifth Edition ( DSM5 ) [ American Psychiatric Association , 2013 ] criterion , include least 5 moderate inattentive impulsivehyperactive symptom , onset several symptom inattentive impulsive/hyperactive trait age 12 . Englishspeaking . Current past history mental retardation , severe sensory impairment deafness blindness , hypomania , mania , psychosis , suicidal homicidal behavior . Current moderate severe symptom mental health condition ADHD , assess use clinical evaluation Adult Self Report Scale , judgment investigator , may jeopardize subject safety interfere ability participate study . Specifically , include current clinical diagnosis moderate severe major depression , score depressive problem subscale ASRS fall clinically significant range . Substance use disorder within past 6 month . Any significant medical condition , , judgment investigator , may jeopardize subject safety . Pregnant female . Inability unwillingness participate study procedure . Contraindication tDCS : history epilepsy , metallic implant head neck , brain stimulators , vagus nerve stimulators , VP shunt , pacemaker . Skin condition may make application , treatment , removal tDCS hardware painful per discretion clinician . Current use medication consider therapeutic ADHD . If subject take medication consider study investigator potentially treat ADHD ( eg . stimulant , atomoxetine , buproprion , modafanil , serotoninnorepinephrine reuptake inhibitor , guanfacine clonidine ) must stop use medication least 5 half life drug physician guidance prior study participation . Subjects enter study would require stop medication optimally comfortably manage clinical concern .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>